aliskiren 300 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Tekturna HCT]

RxCUI
1011752
RxNorm name
aliskiren 300 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Tekturna HCT]
Display name
TEKTURNA HCT (Oral Pill)
Full name
aliskiren 300 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Tekturna HCT]
Term type
SBD
Status
Active
Strength
300-12.5 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-10-26 03:53:03

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102010
Active start
102010
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
aliskiren hemifumarate300 MG / 1 EACHaliskirenaliskiren
hydrochlorothiazide12.5 MG / 1 EACHhydrochlorothiazidehydrochlorothiazide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
aliskiren325646
hydrochlorothiazide5487

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRTekturna HCT (aliskiren 300 MG / HCTZ 12.5 MG) Oral Tablet1NAMES
RxNorm Namealiskiren 300 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Tekturna HCT]1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSBD1ATTRIBUTES
RxCUI10117521CODES
MMSL_CODEBD228321CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 9 matching rows.

NDC11, Source, Active table
NDC11SourceActive
70839031230rxnav_ndcsyes
00078052315rxnav_historical
00078052334rxnav_historical
00078052335rxnav_historical
00078052361rxnav_historical
54868610300rxnav_historical
66828002601rxnav_historical_indirect
70839031201rxnav_historical
70839031290rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8df0ca6a-58cf-41fc-b890-5c7fa5a3792cTekturna HCT 300 MG / 12.5 MG Oral Tablet [PSN] · aliskiren 300 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Tekturna HCT] [SBD] · aliskiren 300 MG / HCTZ 12.5 MG Oral Tablet [Tekturna HCT] [SY] · Tekturna HCT (aliskiren 300 MG / HCTZ 12.5 MG) Oral Tablet [SY]411These highlights do not include all the information needed to use TEKTURNA HCT safely and effectively. See full prescribing information for TEKTURNA HCT. TEKTURNA ® HCT (aliskiren and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 200820221116
40d12d97-152d-4fea-bc59-b69e5c29fde2Tekturna HCT 300 MG / 12.5 MG Oral Tablet [PSN] · aliskiren 300 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Tekturna HCT] [SBD] · aliskiren 300 MG / HCTZ 12.5 MG Oral Tablet [Tekturna HCT] [SY] · Tekturna HCT (aliskiren 300 MG / HCTZ 12.5 MG) Oral Tablet [SY]43These highlights do not include all the information needed to use Tekturna HCT safely and effectively. See full prescribing information for Tekturna HCT . Tekturna HCT (aliskiren and hydrochlorothiazide) T ablets Initial U.S. Approval: 200820090925

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
8df0ca6a-58cf-41fc-b890-5c7fa5a3792cThese highlights do not include all the information needed to use TEKTURNA HCT safely and effectively. See full prescribing information for TEKTURNA HCT. TEKTURNA ® HCT (aliskiren and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 2008Noden Pharma USA, Inc.20221116
097c8077-2215-45d5-9b1b-039ac49499d2National Council for Prescription Drug Programs20120724
4ca0c6b0-9e7e-4cec-ac52-f0e5b61a4963National Council for Prescription Drug Programs20120724
40d12d97-152d-4fea-bc59-b69e5c29fde2These highlights do not include all the information needed to use Tekturna HCT safely and effectively. See full prescribing information for Tekturna HCT . Tekturna HCT (aliskiren and hydrochlorothiazide) T ablets Initial U.S. Approval: 2008Physicians Total Care, Inc.20090925

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC09XARenin-inhibitorsATC1-4aliskiren
ATCC09XARenin-inhibitorsATC1-4aliskiren / hydrochlorothiazide
ATCC03AAThiazides, plainATC1-4hydrochlorothiazide
FDASPLD049971ThiazidesCHEMhas_chemical_structurehydrochlorothiazide
FDASPLN0000175900Renin InhibitorEPChas_epcaliskiren
FDASPLN0000175419Thiazide DiureticEPChas_epchydrochlorothiazide
FDASPLN0000175899Renin InhibitorsMOAhas_moaaliskiren
FDASPLN0000175359Increased DiuresisPEhas_pehydrochlorothiazide
MEDRTD000577AmidesCHEMhas_ingredientaliskiren
MEDRTD005650FumaratesCHEMhas_ingredientaliskiren
MEDRTD006852HydrochlorothiazideCHEMhas_ingredienthydrochlorothiazide
MEDRTD013449SulfonamidesCHEMci_chemclasshydrochlorothiazide
MEDRTD013449SulfonamidesCHEMci_chemclassaliskiren
MEDRTD001002AnuriaDISEASEci_withaliskiren
MEDRTD001002AnuriaDISEASEci_withhydrochlorothiazide
MEDRTD002675Child, PreschoolDISEASEci_withaliskiren
MEDRTD003920Diabetes MellitusDISEASEci_withaliskiren
MEDRTD004342Drug HypersensitivityDISEASEci_withhydrochlorothiazide
MEDRTD004487EdemaDISEASEmay_treathydrochlorothiazide
MEDRTD006333Heart FailureDISEASEmay_treathydrochlorothiazide
MEDRTD006967HypersensitivityDISEASEci_withaliskiren
MEDRTD006973HypertensionDISEASEmay_treataliskiren
MEDRTD006973HypertensionDISEASEmay_treathydrochlorothiazide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treathydrochlorothiazide
MEDRTD011247PregnancyDISEASEci_withhydrochlorothiazide
MEDRTD051437Renal InsufficiencyDISEASEci_withhydrochlorothiazide
MEDRTN0000000181Angiotensin-converting Enzyme InhibitorsMOAci_moaaliskiren
MEDRTN0000000181Angiotensin-converting Enzyme InhibitorsMOAhas_moaaliskiren
MEDRTN0000175899Renin InhibitorsMOAci_moaaliskiren
MEDRTN0000175899Renin InhibitorsMOAhas_moaaliskiren
MEDRTN0000181005Sodium Chloride Symporter InhibitorsMOAhas_moahydrochlorothiazide
MEDRTN0000178477Decreased Blood PressurePEhas_pehydrochlorothiazide
MEDRTN0000178477Decreased Blood PressurePEhas_pealiskiren
MEDRTN0000008579Decreased Distal Tubule Ca++ ExcretionPEhas_pehydrochlorothiazide
MEDRTN0000008669Decreased Intravascular VolumePEhas_pehydrochlorothiazide
MEDRTN0000009274Increased Distal Tubule Cl- ExcretionPEhas_pehydrochlorothiazide
MEDRTN0000009275Increased Distal Tubule H+ ExcretionPEhas_pehydrochlorothiazide
MEDRTN0000009277Increased Distal Tubule K+ ExcretionPEhas_pehydrochlorothiazide
MEDRTN0000009279Increased Distal Tubule Na+ ExcretionPEhas_pehydrochlorothiazide
MEDRTN0000175359Increased DiuresisPEhas_pehydrochlorothiazide
MEDRTN0000009909VasodilationPEhas_pehydrochlorothiazide
MEDRTN0000000042Renal ExcretionPKhas_pkhydrochlorothiazide

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH300 MG / 12.5 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
NAMESPrescribable SynonymTekturna HCT 300 MG / 12.5 MG Oral Tablet
NAMESTallman Synonymaliskiren 300 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet [Tekturna HCT]
SOURCESSourceMultum MediSource Lexicon